Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline vs Azithromycin for Pediatric Mycoplasma Pneumonia
NCT03530319Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of doxycycline in Mycoplasma pneumonia (MP) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Time to Defervescence at 10 days. Status: unknown.
02
Drugs
doxycycline
03
Conditions
Mycoplasma pneumonia (MP)
Beyond the preview
Go deeper on NCT03530319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03530319.